The global capnography devices market size was valued at USD 676.6 million in 2023 and is projected to grow at a CAGR of 10.0% from 2024 to 2030. Expected advancements in technology, the increasing occurrence of respiratory conditions, and backing from government programs will enhance market expansion throughout the projected period. Attributed to its superior reliability and effectiveness, the rising use of capnography for managing respiratory illnesses is forecasted to enhance the clinical performance of these devices in monitoring patients. For instance, in 2022, 4.6% of adults were reported to have received a diagnosis of COPD, emphysema, or chronic bronchitis at some point. Office-based physician visits where COPD was noted in the medical records accounted for 4.2%. There were approximately 791,000 emergency department visits where COPD was the main reason for the visit.

Technological advancements in capnography, including the development of portable and handheld devices, improved accuracy, and seamless integration with other monitoring systems, significantly drive market growth by enhancing usability and expanding application areas. For instance, in June 2022, clinicians could further personalize care with Medtronic’s integration of INVOS regional oximetry (rSO2) and Microstream capnography (CO2) technologies. These continuous monitoring solutions became available on the GE Healthcare CARESCAPE precision monitoring platform, enhancing perioperative and ICU care.

Capnography Devices Market Report Highlights

• Capnography devices find the largest application in sedation and emergency medicine owing to, its usage to optimize prehospital ventilation, correct pediatric emergencies and as a prognostic indicator to maintain pulmonary blood flow.
• Asia Pacific capnography devices market is anticipated to witness significant growth in the market.
• Hospitals dominated the end-use segment of the capnography device market owing to the shifting of preference of hospitals from conventional patient monitoring devices to capnography.
• Moreover, stringent norms for product approval and post-approval performance monitoring which are regulated by authorities such as the U.S. FDA and American Academy of implant may act as a threat for new participants.

Browse through Grand View Research's Medical Devices Industry Research Reports.

• The global energy-based aesthetic devices market sizewas estimated at USD 6.36 billion in 2023 and is projected to grow at a CAGR of 14.2% over the forecast period.
• The global orthopedic splints market sizewas valued at USD 1.69 billion in 2023 and is expected to grow at a CAGR of 9.7% from 2024 to 2030. 

Segments Covered in the Report

Grand View Research has segmented the global capnography devices market based on component, technology, application, type, end use, and region:

Capnography Devices Component Outlook (Revenue, USD Million, 2018 - 2030)

• OEM Modules
  • Infrared Sources
  • Others
• Others

Capnography Devices Technology Outlook (Revenue, USD Million, 2018 - 2030)

• Mainstream
• Sidestream
• Microstream

Capnography Devices Application Outlook (Revenue, USD Million, 2018 - 2030)

• Emergency Medicine
• Pain Medicine
• Procedural Sedation
• Critical Care
• Others

Capnography Devices Type Outlook (Revenue, USD Million, 2018 - 2030)

• Hand-held
• Stand-alone
• Multi-parameter

Capnography Devices End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals
• Ambulatory Care Centers
• Others

Capnography Devices Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • U.S.
  • Canada
• Europe
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Russia
• Asia Pacific
  • China
  • India
  • New Zealand
  • Singapore
  • Japan
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa      
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Order a free sample PDF of the Capnography Devices Market Intelligence Study, published by Grand View Research.